{
  "hash": "b73ab62c72712067f0b7ea18ba5c3fe6",
  "result": {
    "markdown": "---\ntitle: \"Trends in Invasive Melanoma Thickness in Norway, 1983â€“2019\"\nauthor: \"Raju Rimal\"\ndate: \"30 Oct, 2024\"\ninstitute: |\n  Oslo Centre for Biostatistics and Epidemiology (OCBE)<br>\n  Department of Biostatistics, UiO<br>\n  Presented at: <span class=\"text-green conf\" >Cancer Registry of Norway</span>\ncode-overflow: scroll\ndate-format: \"DD MMMM YYYY\"\nbibliography: References.bib\ncitations-hover: true\npreview-links: true\nknitr:\n  opts_chunk: \n    collapse: true\n    comment: \"#>\" \nexecute: \n  echo: false\n  warning: false\nformat: \n  revealjs:\n    center-title-slide: false\n    slide-number: true\n    auto-animate-easing: ease-in-out\n    auto-animate-unmatched: false\n    auto-animate-duration: 0.5\n    navigation-mode: linear\n    transition: none\n    background-transition: none\n    template-partials:\n      - title-slide.html\n    theme: [default, custom.scss]\n    logo: Images/Logos/UiO-Logo.png\n    title-slide-attributes:\n      data-background-color: \"#FCFCFC\"\n      data-background-image: Images/melo.svg\n      data-background-opacity: \"0.75\"\n      data-background-size: auto 80%\n      data-background-position: 90% center\neditor_options: \n  chunk_output_type: console\nnocite: \"@*\"\n---\n\n\n# {background-image=\"Images/Journal-Article-Head.jpg\" background-size=\"contain\"}\n\n# Somewhere, something incredible is waiting to be known. {.center .quote visibility=\"hidden\"}\n\n::: {style=\"text-align:right; border-right: 2px solid #0f0f0f; padding-right: 15px; margin-top: 50px; color: #0f0f0f;\"}\nDr. Carl Sagan (1934--1996)\n:::\n\n::: {style=\"text-align:right; border-right: 2px solid gray; padding-right: 15px; font-size: 80%; color: gray\"}\nAmerican astronomer and science communicator\n:::\n\n# Outline {.ai .dark .columns background-image=\"Images/AI/Steps-Spiral.jpg\" background-position=\"right\" background-size=\"auto 100%\" visibility=\"hidden\"}\n\n::: {.column width=\"50%\"}\n-   [Background](#background)\n\n-   [Research Objective](#aim)\n\n-   [Case series](#case-series)\n\n-   [Analysis](#analysis)\n\n-   [Summary](#summary)\n:::\n\n::: {.column width=\"50%\"}\n:::\n\n# {background-image=\"Images/Backgrounds/Background.jpg\"}\n\n::: {.huge}\nBackground\n:::\n\n##  {.center background-image=\"Images/GLOBOCAN.svg\" background-position=\"right\" background-size=\"50% 90%\"}\n\n::: columns\n::: {.column width=\"30%\"}\n![](Images/melo.svg){width=\"100%\" style=\"opacity:68%;\" fig-align=\"center\"}\n:::\n\n::: {.column width=\"70%\"}\n:::\n:::\n\n## {background-image=\"Images/SnowField.jpg\" background-size=\"cover\"}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nWhy this study and what we know \n:::\n\n::: {.callout-tip}\n#### Understanding melanoma trends is:\n\n- crucial for prevention and treatment strategies\n- allocating resources effectively and\n- prepare tailored interventions based on recent data\n:::\n\n\n::: {.callout-note}\n#### Tumour thickness\n\n- **Tumour thickness** is the most **important prognostic factor**\n- **More thinner tumours are diagnosed** than thicker\n\n:::\n\n\n\n\n```{=html}\n<!--\n# Color schemes (uchicago):\n#   Default: default_uchicago:\n#     #800000 #767676 #FFA319 #8A9045 #155F83 \n#     #C16622 #8F3931 #58593F #350E20\n#   Dark: dark_uchicago:\n#     #800000 #767676 #CC8214 #616530 #0F425C \n#     #9A5324 #642822 #3E3E23 #350E20 \n#   Light: light_uchicago:\n#     #800000 #D6D6CE #FFB547 #ADB17D #5B8FA8 \n#     #D49464 #B1746F #8A8B79 #725663\n#   White:\n#     #FFFAFA #FCFCFC #FFFDFD #FCFFE0 #F9FCFF \n#     #FFFCFB #FFFAFA #FCFDE5 #FFF8FA\n-->\n```\n\n\n# Research Objective {#aim .center .middle}\n\nDescribe population-based long-term **trends in melanoma incidence** and **tumour thickness** as well as by sex, age, calendar period, residential region, and anatomic site.\n\n# {background-image=\"Images/Backgrounds/Case-Series.jpg\"}\n\n::: {.huge}\nCase series \n:::\n\n\n## {.top}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nData from Cancer Registry of Norway \n:::\n\n![](Images/Data-Timeline.svg){width=\"100%\"}\n\n::: columns\n::: {.column width=\"80%\"}\n::: {.callout-note appearance=\"minimal\"}\n- All histologically verified first primary invasive melanoma\n- **Variables**: tumour thickness, sex, age at diagnosis, vital status, anatomic site, histopathological subtype\n:::\n:::\n\n::: {.column width=\"20%\"}\n![](Images/Logos/CRN-Logo.svg){fig-align=\"right\" width=\"100%\"}\n:::\n:::\n\n## {.middle}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nTumour thickness categories \n:::\n\n![Source: [`https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/tnm-staging`](https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/tnm-staging)](Images/T-Stages.svg){width=\"100%\" fig-align=\"left\"}\n\n\n## {}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nBasic characteristics of data\n:::\n\n\n::: {.cell}\n\n:::\n\n\n::: {.columns .grid style=\"grid-template-columns: 2fr 1fr; align-items: flex-start;\"}\n::: {.column .grid style=\"grid-template-rows: auto 1fr 1fr;\"}\n\n\n### Age and Thickness\n\n\n::: {.cell}\n::: {.cell-output-display}\n```{=html}\n<div id=\"spbjysilpv\" style=\"padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:100%;height:auto;\">\n<style>#spbjysilpv table {\n  font-family: 'IBM Plex Mono', system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\n  -webkit-font-smoothing: antialiased;\n  -moz-osx-font-smoothing: grayscale;\n}\n\n#spbjysilpv thead, #spbjysilpv tbody, #spbjysilpv tfoot, #spbjysilpv tr, #spbjysilpv td, #spbjysilpv th {\n  border-style: none;\n}\n\n#spbjysilpv p {\n  margin: 0;\n  padding: 0;\n}\n\n#spbjysilpv .gt_table {\n  display: table;\n  border-collapse: collapse;\n  line-height: normal;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 60%;\n  font-weight: normal;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: 100%;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_caption {\n  padding-top: 4px;\n  padding-bottom: 4px;\n}\n\n#spbjysilpv .gt_title {\n  color: #333333;\n  font-size: 125%;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#spbjysilpv .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 3px;\n  padding-bottom: 5px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#spbjysilpv .gt_heading {\n  background-color: #FFFFFF;\n  text-align: center;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_bottom_border {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_col_headings {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_col_heading {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: bold;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#spbjysilpv .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: bold;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#spbjysilpv .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#spbjysilpv .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#spbjysilpv .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 5px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#spbjysilpv .gt_spanner_row {\n  border-bottom-style: hidden;\n}\n\n#spbjysilpv .gt_group_heading {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: bold;\n  text-transform: inherit;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  text-align: left;\n}\n\n#spbjysilpv .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: bold;\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  vertical-align: middle;\n}\n\n#spbjysilpv .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#spbjysilpv .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#spbjysilpv .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#spbjysilpv .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#spbjysilpv .gt_stub_row_group {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n  vertical-align: top;\n}\n\n#spbjysilpv .gt_row_group_first td {\n  border-top-width: 2px;\n}\n\n#spbjysilpv .gt_row_group_first th {\n  border-top-width: 2px;\n}\n\n#spbjysilpv .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#spbjysilpv .gt_first_summary_row {\n  border-top-style: solid;\n  border-top-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_first_summary_row.thick {\n  border-top-width: 2px;\n}\n\n#spbjysilpv .gt_last_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#spbjysilpv .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_last_grand_summary_row_top {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: double;\n  border-bottom-width: 6px;\n  border-bottom-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#spbjysilpv .gt_table_body {\n  border-top-style: solid;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#spbjysilpv .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#spbjysilpv .gt_sourcenote {\n  font-size: 90%;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#spbjysilpv .gt_left {\n  text-align: left;\n}\n\n#spbjysilpv .gt_center {\n  text-align: center;\n}\n\n#spbjysilpv .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#spbjysilpv .gt_font_normal {\n  font-weight: normal;\n}\n\n#spbjysilpv .gt_font_bold {\n  font-weight: bold;\n}\n\n#spbjysilpv .gt_font_italic {\n  font-style: italic;\n}\n\n#spbjysilpv .gt_super {\n  font-size: 65%;\n}\n\n#spbjysilpv .gt_footnote_marks {\n  font-size: 75%;\n  vertical-align: 0.4em;\n  position: initial;\n}\n\n#spbjysilpv .gt_asterisk {\n  font-size: 100%;\n  vertical-align: 0;\n}\n\n#spbjysilpv .gt_indent_1 {\n  text-indent: 5px;\n}\n\n#spbjysilpv .gt_indent_2 {\n  text-indent: 10px;\n}\n\n#spbjysilpv .gt_indent_3 {\n  text-indent: 15px;\n}\n\n#spbjysilpv .gt_indent_4 {\n  text-indent: 20px;\n}\n\n#spbjysilpv .gt_indent_5 {\n  text-indent: 25px;\n}\n\n#spbjysilpv .katex-display {\n  display: inline-flex !important;\n  margin-bottom: 0.75em !important;\n}\n\n#spbjysilpv div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {\n  height: 0px !important;\n}\n</style>\n<table class=\"gt_table\" data-quarto-disable-processing=\"false\" data-quarto-bootstrap=\"false\">\n  <thead>\n    <tr class=\"gt_col_headings\">\n      <th class=\"gt_col_heading gt_columns_bottom_border gt_left\" rowspan=\"1\" colspan=\"1\" scope=\"col\" id=\"a::stub\"></th>\n      <th class=\"gt_col_heading gt_columns_bottom_border gt_center\" rowspan=\"1\" colspan=\"1\" scope=\"col\" id=\"a1983-1999\">1983-1999</th>\n      <th class=\"gt_col_heading gt_columns_bottom_border gt_center\" rowspan=\"1\" colspan=\"1\" scope=\"col\" id=\"a2008-2019\">2008-2019</th>\n    </tr>\n  </thead>\n  <tbody class=\"gt_table_body\">\n    <tr class=\"gt_group_heading_row\">\n      <th colspan=\"3\" class=\"gt_group_heading\" scope=\"colgroup\" id=\"Age at diagnosis, Median (Q1, Q3)\">Age at diagnosis, Median (Q1, Q3)</th>\n    </tr>\n    <tr class=\"gt_row_group_first\"><th id=\"stub_1_1\" scope=\"row\" class=\"gt_row gt_left gt_stub\" style=\"text-align: right;\">Women</th>\n<td headers=\"Age at diagnosis, Median (Q1, Q3) stub_1_1 1983-1999\" class=\"gt_row gt_center\">56 (42, 71)</td>\n<td headers=\"Age at diagnosis, Median (Q1, Q3) stub_1_1 2008-2019\" class=\"gt_row gt_center\">63 (50, 75)</td></tr>\n    <tr><th id=\"stub_1_2\" scope=\"row\" class=\"gt_row gt_left gt_stub\" style=\"text-align: right;\">Men</th>\n<td headers=\"Age at diagnosis, Median (Q1, Q3) stub_1_2 1983-1999\" class=\"gt_row gt_center\">59 (46, 71)</td>\n<td headers=\"Age at diagnosis, Median (Q1, Q3) stub_1_2 2008-2019\" class=\"gt_row gt_center\">67 (56, 76)</td></tr>\n    <tr class=\"gt_group_heading_row\">\n      <th colspan=\"3\" class=\"gt_group_heading\" scope=\"colgroup\" id=\"Tumour thickness, Median (Q1, Q3)\">Tumour thickness, Median (Q1, Q3)</th>\n    </tr>\n    <tr class=\"gt_row_group_first\"><th id=\"stub_1_3\" scope=\"row\" class=\"gt_row gt_left gt_stub\" style=\"text-align: right;\">Women</th>\n<td headers=\"Tumour thickness, Median (Q1, Q3) stub_1_3 1983-1999\" class=\"gt_row gt_center\">1 (0.6, 2)</td>\n<td headers=\"Tumour thickness, Median (Q1, Q3) stub_1_3 2008-2019\" class=\"gt_row gt_center\">0.9 (0.5, 1.8)</td></tr>\n    <tr><th id=\"stub_1_4\" scope=\"row\" class=\"gt_row gt_left gt_stub\" style=\"text-align: right;\">Men</th>\n<td headers=\"Tumour thickness, Median (Q1, Q3) stub_1_4 1983-1999\" class=\"gt_row gt_center\">1.3 (0.74, 2.8)</td>\n<td headers=\"Tumour thickness, Median (Q1, Q3) stub_1_4 2008-2019\" class=\"gt_row gt_center\">1 (0.6, 2.3)</td></tr>\n  </tbody>\n  \n  \n</table>\n</div>\n```\n:::\n:::\n\n\n\n::: {.small .callout-tip appearance=\"minimal\"}\n**Missing tumour thickness** decreased from 3,714 (26.3%) in 1983--1999 to 1,742 (7.7%)\n:::\n\n\n:::\n\n::: {.column}\n### Notes\n\n::: {.small}\n::: {.callout-tip appearance=\"minimal\"}\n**Women**: 23,459 (52%) and **Men**: 22,065 (48%)\n:::\n\n::: {.callout-note appearance=\"minimal\"}\nIncreased age at diagnosis\n:::\n::: {.callout-note appearance=\"minimal\"}\nReduced Tumour thickness at diagnosis\n:::\n::: {.callout-note appearance=\"minimal\"}\nMen were diagnsed at older age and thicker tumour than women\n:::\n:::\n:::\n:::\n\n::: notes\n**Missing in distant cases:** It is quite common that thickness is missing for the most serios cases.\n\n(Thickness is the most important prognosis factor in the cases with localized mealnoma)\n:::\n\n# {background-image=\"Images/Backgrounds/Analysis.jpg\"}\n\n::: huge\nAnalysis & <br>Results \n:::\n\n## {background-image=\"Images/Drammen-Wide.jpg\" background-size=\"cover\"}\n\n::: {.huge style=\"font-size:2.7em; font-weight:bolder; text-shadow: 1px 1px 2px #3d3d3d;\"}\nMethods \n:::\n\n::: {.columns}\n::: {.column width=\"75%\"}\n\n::: r-fit-text\n\nâ–¢ Multiple imputation\n\n::: fragment\nâ–¢ Age-adjusted incidence rates\n:::\n\n::: fragment\nâ–¢ Segmented regression\n:::\n\n:::\n\n:::\n::: {.column width=\"40%\"}\n:::\n:::\n\n## {}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nMelanoma incidence trend\n:::\n\n::: {.columns .small .grid style=\"grid-template-columns: 1fr 65%; align-content:baseline; align-items:flex-end;\"}\n::: column\n### By sex and T category\n\n::: {.callout-warning appearance=\"simple\" icon=\"false\"}\n**Increased incidence rates** in all T-categories\n:::\n\n::: {.callout-warning appearance=\"simple\" icon=\"false\"}\n#### T1 melanoma trend\n\n  - 1983â€“1989/90: Steep rise\n  - 1990â€“2004: Plateau\n  - 2005â€“2019: Sharp increase again\n:::\n:::\n\n::: column\n![](Plots/Spline-BySexTstage.svg){width=\"100%\"}\n:::\n:::\n\n## {}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nMelanoma incidence trend\n:::\n\n### By anatomic site\n![](Plots/Spline-BySexTstageSite.svg)\n\n::: {.overlay-box .smaller .fragment .fade-in-then-out .absolute width=\"30%\" height=\"20%\" right=\"0\" top=\"0\"}\n::: {#overlay-box-note .callout-note appearance=\"default\" icon=\"false\"}\n### Overall:\nT1 melanoma had the highest incidence across all sites. \n:::\n:::\n\n::: {.overlay-box .smaller .fragment .fade-in-then-out .absolute width=\"30%\" height=\"20%\" right=\"0\" top=\"0\"}\n::: {#overlay-box-note .callout-note appearance=\"default\" icon=\"false\"}\n### Overall:\nT1 plateau was not seen for all sites.\n:::\n:::\n\n::: {.overlay-box .smaller .fragment .fade-in-then-out .absolute width=\"30%\" height=\"24%\" right=\"0\" top=\"0\"}\n::: {#overlay-box-note .callout-warning appearance=\"default\" icon=\"false\"}\n### In women:\nHigh and increasing incidence on the trunk and lower limbs with plateau in T1.\n:::\n:::\n\n::: {.overlay-box .smaller .fragment .fade-in-then-out .absolute width=\"30%\" height=\"24%\" right=\"0\" top=\"0\"}\n::: {#overlay-box-note .callout-warning appearance=\"default\" icon=\"false\"}\n### In men:\nHighest incidence in trunk but lower incidence in lower limbs than women.\n:::\n:::\n\n::: {.overlay-box .smaller .fragment .absolute width=\"30%\" height=\"24%\" right=\"0\" top=\"0\"}\n::: {#overlay-box-note .callout-warning appearance=\"default\" icon=\"false\"}\n### In men:\nHigher and increasing head/neck incidence compared to women, mainly in thicker melanoma.\n:::\n:::\n\n## {}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nMelanoma incidence trend\n:::\n\n### By histopathological subtype\n![](Plots/Spline-BySexTstageType.svg)\n\n::: {.smaller .overlay-box .fragment .fade-in-then-out .absolute width=\"20%\" height=\"60%\" right=\"-5%\" top=\"20%\" style=\"margin-top: 15px;\"}\n::: {#side-box-note .callout-note appearance=\"default\"}\n#### Superficial spreading\n- Mirrors overall pattern.\n- Higher in women than men.\n- Stable/ decreasing trend in thicker melanoma.\n- Increasing T2 in the recent years.\n:::\n:::\n\n::: {.smaller .overlay-box .fragment .fade-in-then-out .absolute width=\"20%\" height=\"60%\" right=\"-5%\" top=\"20%\" style=\"margin-top: 15px;\"}\n::: {#side-box-note .callout-note appearance=\"default\"}\n#### Nodular\n- Higher incidence of thicker melanoma.\n- Higher in men than women.\n- Stable/decreasing recent incidence trend.\n- Percentage in T3 and T4 was increasing.\n:::\n:::\n\n# Summary {#summary .smaller background-image=\"Images/Mountain-from-plane.jpg\" background-position=\"right\" background-size=\"50% 100%\"}\n\n::: columns\n::: column\n::: {.fragment .semi-fade-out fragment-index=\"1\"}\n- Steep increase in thin melanoma until 1989/90 followed by plateau and steep increase again after 2004/05.\n:::\n\n::: {.fragment .fade-in-then-semi-out fragment-index=\"1\"}\n- Higher and more increasing incidence in men than women.\n:::\n\n::: {.fragment .fade-in-then-semi-out}\n- Nodular melanoma had higher incidence of thicker tumour, more in men compared to women.\n:::\n\n::: {.fragment .fade-in-then-semi-out}\n- Need for increased melanoma awareness in men.\n- Need for more awareness of new and rapidly growing pigmented lesions in older people\n:::\n:::\n\n::: column\n:::\n:::\n\n<!-- #  {visibility=\"hidden\"} -->\n\n##  {#logo-profile .center .smaller}\n\n::: columns\n::: {.column width=\"30%\"}\n### Collaborators\n\n::: collab-logo\n![](Images/Logos/UiO-Logo.png){#uio width=\"100%\"} ![](Images/Logos/CRN-Logo.svg){#crn width=\"100%\"} ![](Images/Logos/QIMR-Logo.png){#qimr width=\"100%\"} ![](Images/Logos/IARC-Logo.png){#iarc width=\"100%\"} ![](Images/Logos/OUS-Logo.png){#ous width=\"100%\"}\n\n::: {#funding}\n**Funded by:** ![](Images/Logos/RNF-Logo.svg){#rnf width=\"100%\"}\n:::\n:::\n:::\n\n::: {.column width=\"70%\"}\n### Coauthors\n\n::: profile-container\n\n::: {.profile-card}\n![](Images/Profile/01-profile-raju-rimal.png){width=\"100%\"}\n<p>Raju Rimal</p>\n:::\n::: {.profile-card}\n![](Images/Profile/02-profile-trude-e-robsahm.png){width=\"100%\"}\n<p>Trude E Robsahm</p>\n:::\n::: {.profile-card}\n![](Images/Profile/03-profile-adele-green.png){width=\"100%\"}\n<p>Adele Green</p>\n:::\n::: {.profile-card}\n![](Images/Profile/04-profile-reza-ghiasvand.png){width=\"100%\"}\n<p>Reza Ghiasvand</p>\n:::\n::: {.profile-card}\n![](Images/Profile/05-profile-corina-s-rueegg.png){width=\"100%\"}\n<p>Corina S Rueegg</p>\n:::\n::: {.profile-card}\n![](Images/Profile/06-profile-assia-bassarova.png){width=\"100%\"}\n<p>Assia Bassarova</p>\n:::\n::: {.profile-card}\n![](Images/Profile/07-profile-petter-gjersvik.png){width=\"100%\"}\n<p>Petter Gjersvik</p>\n:::\n::: {.profile-card}\n![](Images/Profile/08-profile-elisabete-weiderpass.png){width=\"100%\"}\n<p>Elisabete Weiderpass</p>\n:::\n::: {.profile-card}\n![](Images/Profile/09-profile-odd-o-aalen.png){width=\"100%\"}\n<p>Odd O Aalen</p>\n:::\n::: {.profile-card}\n![](Images/Profile/10-profile-bjÃ¸rn-mÃ¸ller.png){width=\"100%\"}\n<p>BjÃ¸rn MÃ¸ller</p>\n:::\n::: {.profile-card}\n![](Images/Profile/11-profile-flavie-perrier.png){width=\"100%\"}\n<p>Flavie Perrier</p>\n:::\n::: {.profile-card}\n![](Images/Profile/12-profile-marit-b-veierÃ¸d.png){width=\"100%\"}\n<p>Marit B VeierÃ¸d</p>\n:::\n\n:::\n:::\n:::\n\n# {background-image=\"Images/Backgrounds/Extra-Slides.jpg\"}\n\n::: {.huge style=\"color:#f0f0f0cc;\"}\nExtra<br>slides \n:::\n\n## {}\n\n::: {.huge style=\"font-size:1.5em; font-weight:bolder; text-shadow: 1px 1px 2px #3D3D3D;\"}\nMelanoma incidence trend\n:::\n\n### By period and age at diagnosis\n![](Plots/APC-LexisPlot.svg)\n\n\n##  {background-image=\"Images/Thank-You.png\" background-size=\"auto 90%\"}\n\n## References {.smaller}\n\n::: {#refs}\n:::\n",
    "supporting": [
      "index_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-after-body": [
        "\n<script>\n  // htmlwidgets need to know to resize themselves when slides are shown/hidden.\n  // Fire the \"slideenter\" event (handled by htmlwidgets.js) when the current\n  // slide changes (different for each slide format).\n  (function () {\n    // dispatch for htmlwidgets\n    function fireSlideEnter() {\n      const event = window.document.createEvent(\"Event\");\n      event.initEvent(\"slideenter\", true, true);\n      window.document.dispatchEvent(event);\n    }\n\n    function fireSlideChanged(previousSlide, currentSlide) {\n      fireSlideEnter();\n\n      // dispatch for shiny\n      if (window.jQuery) {\n        if (previousSlide) {\n          window.jQuery(previousSlide).trigger(\"hidden\");\n        }\n        if (currentSlide) {\n          window.jQuery(currentSlide).trigger(\"shown\");\n        }\n      }\n    }\n\n    // hookup for slidy\n    if (window.w3c_slidy) {\n      window.w3c_slidy.add_observer(function (slide_num) {\n        // slide_num starts at position 1\n        fireSlideChanged(null, w3c_slidy.slides[slide_num - 1]);\n      });\n    }\n\n  })();\n</script>\n\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}